Hims & Hers Health (HIMS) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.37
- EPS estimate
- −$0.05
- EPS surprise
- −642.97%
- Revenue surprise
- +7.77%
- Revenue
- $753.2M
- Revenue estimate
- $698.9M
- Reported
- Aug 10, 2026
Hims & Hers Health reported Q2 2026 results on August 10, 2026. It posted a loss of $0.37 per share, much wider than the $0.05 loss expected, a 642.97% miss. Revenue was $753.2 million, about 7.8% above the $698.9 million estimate. Compared with Q2 2025, revenue rose about 38% from $544.8 million, while EPS moved from a $0.17 profit to a loss.
Revenue has grown quickly through the table. Annual revenue rose from $526.9 million in 2022 to $2.35 billion in 2025, about 4.5 times as much, and Q2 2026 set the quarterly high. The company lost money in every quarter of 2022 and in the first three quarters of 2023, then posted annual EPS of $0.54 in 2024 and $0.51 in 2025. The first half of 2026 brought back-to-back losses of $0.40 and $0.37 per share, the two weakest quarters in the table. Hims & Hers beat EPS estimates in 12 of the last 20 quarters.
Q3 results came out between November 3 and November 7 in each of the past four years, so the next report would likely land in early November 2026. It will show whether revenue growth continues and whether the quarterly losses narrow.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$0.05 | −$0.37 | −642.97% | $753.2M | SEC |
| Q1 2026 | May 11, 2026 | $0.03 | −$0.40 | −1674.80% | $608.1M | SEC |
| Q4 2025 | Feb 23, 2026 | $0.04 | $0.08 | +100.50% | $617.8M | SEC |
| Q3 2025 | Nov 3, 2025 | $0.09 | $0.06 | −36.37% | $599.0M | SEC |
| Q2 2025 | Aug 4, 2025 | $0.15 | $0.17 | +12.73% | $544.8M | SEC |
| Q1 2025 | May 5, 2025 | $0.12 | $0.20 | +65.43% | $586.0M | SEC |
| Q4 2024 | Feb 24, 2025 | $0.11 | $0.11 | −2.91% | $481.1M | SEC |
| Q3 2024 | Nov 4, 2024 | $0.11 | $0.32 | +187.77% | $401.6M | SEC |
| Q2 2024 | Aug 5, 2024 | $0.04 | $0.06 | +34.53% | $315.6M | SEC |
| Q1 2024 | May 6, 2024 | $0.01 | $0.05 | +385.44% | $278.2M | SEC |
| Q4 2023 | Feb 26, 2024 | −$0.02 | $0.01 | +144.84% | $246.6M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.04 | −$0.04 | −12.04% | $226.7M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.05 | −$0.03 | +38.14% | $207.9M | SEC |
| Q1 2023 | May 8, 2023 | −$0.02 | −$0.05 | −142.72% | $190.8M | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.06 | −$0.05 | +14.53% | $167.2M | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.10 | −$0.09 | +11.24% | $144.8M | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.08 | −$0.10 | −23.15% | $113.6M | SEC |
| Q1 2022 | May 9, 2022 | −$0.08 | −$0.08 | +3.73% | $101.3M | SEC |
| Q4 2021 | Feb 22, 2022 | −$0.09 | −$0.15 | −68.92% | $84.7M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.08 | −$0.08 | +0.25% | $74.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Hims & Hers Health (HIMS) last report earnings?
Hims & Hers Health last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did HIMS beat earnings estimates?
No. Hims & Hers Health reported EPS of −$0.37 for Q2 2026 against a −$0.05 estimate — a 642.97% miss.
How much revenue did HIMS report last quarter?
Hims & Hers Health reported $753.2M in revenue for Q2 2026, against a consensus estimate of $698.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.